Lawrenceville, Georgia — According to state and local development sources, UCB plans to invest $2 Billion to build out 460,000 square feet of new space in Lawrenceville. The company is creating 330 new jobs at this facility. The company plans to occupy the new space in Lawrenceville, on or about April 1, 2028. According to the company website At UCB, we believe everyone deserves to live the best life they can – as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value – not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact – today and into the future. We’re inspired by patients, driven by science.

To learn more about UCB, visit https://www.ucb-usa.com/

Company Contact:
UCB
1950 Lake Park Drive
Smyrna, GA30080
Phone: 770-970-7500
LinkedIn Link: https://www.linkedin.com/company/ucb-pharma/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.